TEVA

NYSE Teva Pharmaceutical Industries Limited

Oct 4, 2026 · 2:28 AM ET EOD Market Closed

$39.53 ↑ +0.00 (+0.00%) Trading Up from the previous close of $39.53, $0.28 below the day’s high of $39.81

YTD change: +26.66%
vs 20-day SMA: +2.64%
vs 200-day SMA: +17.53%

Price ranges

Previous day

$39.05 $39.81

open $39.31 close $39.53

+$0.22 (+0.56%)

Today

$39.05 $39.81

$39.53

Past week

$38.30 $40.28

from $40.22 now $39.53

-$0.69 (-1.72%)

Past month

$35.42 $40.79

from $37.49 now $39.53

+$2.04 (+5.44%)

This year

$27.93 $40.79

from $31.21 now $39.53

+$8.32 (+26.66%)

Price & Performance

+9.71 (+32.56%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 23.3% away from all-time highs of $51.51
TEVA is up 27% since the beginning of the year
TEVA is up 97% over the past 12 months
TEVA is up 5% over the past 1 month
3% of all TEVA investors are betting against TEVA

TEVA reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +97.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $0.02

Earnings momentum +97.2% Quarterly EPS growth

Quarterly change +97.2%

Valuation

P/E ratio 66.00

Beta 0.54

Balance sheet & scale

Income$699.6K

Revenue$17.5B

Cash$3.7B

Debt$16.9M

Income / Debt 0.04×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $46.1B

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Competitor comparison

Ticker	Company	Price	Change
LLY	Eli Lilly and Company	$1,142.85	-0.61%
JNJ	Johnson & Johnson	$256.03	-1.02%
ABBV	AbbVie, Inc.	$262.82	+1.11%
MRK	Merck & Co., Inc.	$144.30	+0.34%
RHHVF	Roche Holding Ltd	$428.22	-3.25%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.